262 related articles for article (PubMed ID: 17534943)
1. Treatment with levodopa and risk for malignant melanoma.
Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma in early Parkinson's disease: the DATATOP trial.
Constantinescu R; Romer M; Kieburtz K;
Mov Disord; 2007 Apr; 22(5):720-2. PubMed ID: 17373726
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma and other types of cancer preceding Parkinson disease.
Olsen JH; Friis S; Frederiksen K
Epidemiology; 2006 Sep; 17(5):582-7. PubMed ID: 16837822
[TBL] [Abstract][Full Text] [Related]
4. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
Zanetti R; Loria D; Rosso S
Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
[TBL] [Abstract][Full Text] [Related]
5. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
[TBL] [Abstract][Full Text] [Related]
6. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
Elbaz A; Peterson BJ; Bower JH; Yang P; Maraganore DM; McDonnell SK; Ahlskog JE; Rocca WA
Mov Disord; 2005 Jun; 20(6):719-25. PubMed ID: 15704188
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease, levodopa-use and the risk of melanoma.
Vermeij JD; Winogrodzka A; Trip J; Weber WE
Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
[TBL] [Abstract][Full Text] [Related]
9. Skin cancer and Parkinson's disease.
Ferreira JJ; Neutel D; Mestre T; Coelho M; Rosa MM; Rascol O; Sampaio C
Mov Disord; 2010 Jan; 25(2):139-48. PubMed ID: 20063399
[TBL] [Abstract][Full Text] [Related]
10. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
11. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Pfützner W; Przybilla B
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Parkinson's disease in Spain.
Grandas F; Kulisevsky J
Mov Disord; 2003 Jan; 18(1):87-9. PubMed ID: 12518304
[TBL] [Abstract][Full Text] [Related]
14. Current controversies: levodopa in the treatment of Parkinson's disease.
Sharma JC; Vassallo M; Ross IN
Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
[No Abstract] [Full Text] [Related]
15. Safety of long-term levodopa therapy in malignant melanoma.
Woofter MJ; Manyam BV
Clin Neuropharmacol; 1994 Aug; 17(4):315-9. PubMed ID: 9316678
[TBL] [Abstract][Full Text] [Related]
16. Levodopa therapy and the risk of malignant melanoma.
Siple JF; Schneider DC; Wanlass WA; Rosenblatt BK
Ann Pharmacother; 2000 Mar; 34(3):382-5. PubMed ID: 10917387
[TBL] [Abstract][Full Text] [Related]
17. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
[TBL] [Abstract][Full Text] [Related]
18. Punding prevalence in Parkinson's disease.
Miyasaki JM; Al Hassan K; Lang AE; Voon V
Mov Disord; 2007 Jun; 22(8):1179-81. PubMed ID: 17230464
[TBL] [Abstract][Full Text] [Related]
19. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
Ceravolo R; Cossu G; Bandettini di Poggio M; Santoro L; Barone P; Zibetti M; Frosini D; Nicoletti V; Manganelli F; Iodice R; Picillo M; Merola A; Lopiano L; Paribello A; Manca D; Melis M; Marchese R; Borelli P; Mereu A; Contu P; Abbruzzese G; Bonuccelli U
Mov Disord; 2013 Sep; 28(10):1391-7. PubMed ID: 23836370
[TBL] [Abstract][Full Text] [Related]
20. [Early treatment of Parkinson's disease with levodopa].
Odekerken VJ; Post B; Verschuur CV; de Bie RM
Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
